Skip to content

Inna Aroutiounova, M.D.

NPI 1174523351ActiveIndividual· Internal Medicine, Rheumatology· Indianapolis, IN

Internal Medicine, Rheumatology (M.D.) in Indianapolis, Indiana, licensed in IN, with an NPI issued in July 2005. Enrolled in Medicare as practitioner - rheumatology. Takeda Pharmaceuticals U.S.A., Inc. reported $52,827 in payments in 2025, mostly consulting fees.

Overview

NPI1174523351
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedJul 28, 2005
Last updated in NPPESApr 14, 2015

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Rheumatology Primary207RR0500X01056223AIN

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Rheumatology (IN)

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$52,827 · 23 payments from 1 company
  • 2024$39,479 · 21 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Takeda Pharmaceuticals U.S.A., Inc.$52,82723

What the 2025 payments were for

  • Consulting Fee$52,827 · 23 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Rheumatology providers in Indianapolis

All Internal Medicine, Rheumatology providers in Indiana →